首页 | 本学科首页   官方微博 | 高级检索  
检索        

川芎嗪与噻氯匹啶联合治疗缺血性脑血管病的临床对比研究
引用本文:吴毓玲.川芎嗪与噻氯匹啶联合治疗缺血性脑血管病的临床对比研究[J].海峡药学,2004,16(3):91-93.
作者姓名:吴毓玲
作者单位:厦门市湖里医院内科,厦门,361006
摘    要:目的 观察川芎嗪与噻氯匹啶联合治疗缺血性脑血管病的临床疗效。方法 76例病人,男42例,女34例,随机分为3组。川芎嗪加噻氯匹啶32例;对照组1:单用噻氯匹啶20例;对照组2:单用川芎嗪24例,1个月为1个疗程。结果 治疗组总有效率(96.85%),优于对照组1及对照组2(70%,87.5%),1年后复发率9%,对照组为13.6%和11.3%。结论 川芎嗪加噻氯匹啶治疗缺血性脑血管病优于单用川芎嗪或噻氯匹啶的治疗。

关 键 词:川芎嗪  噻氯匹啶  缺血性脑血管病
文章编号:1006-3765(2004)03-0091-03

Clinical Comparison in Treating Ischemic Vascular Diseases with Ligustrazine and Por Ticlopidine
WU Yu-ling.Clinical Comparison in Treating Ischemic Vascular Diseases with Ligustrazine and Por Ticlopidine[J].Strait Pharmaceutical Journal,2004,16(3):91-93.
Authors:WU Yu-ling
Abstract:OBJECTIVE To observe the effect of ligustrazine and Ticlopidine on ischemic vascular diseases.METHODS 76 patients of ischemic vascular diseases that male 42,female 34were divided into three groups treated groups:Ligustrazine and Ticlopidine with 32 patients;Control 1:Ticlopidine with 20 patients and Control 2:Ligustrazine with 24 patients.The peried of treatment was one month.RESULTS The total efficacy rate was 96.85%of treated group,which was better than Control 1(13.6%)and control group 2(11.3%)after one year.CONCLUSION Treating ischemicvascular diseases with Ligustrazine and ticlopidine is better than with Ticlopidine or Ligustrazine alone.
Keywords:Ligustrazine Ticlopidine Ischemic vascular disases
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号